Email This News Release

"Dotter Inc., a Korean Leading Bioabsorbable Stent Company Announced the Start of Clinical Trial to Evaluate the Safety and Effectiveness of the Company's Drug-Eluting Bioabsorbable Stent Dotter BRS"

Your privacy is important to us. We will never share your email or other information with a third party.